Weighted gene co-expression network of tumor and normal liver transcriptomes identifies prognostic signature in hepatocellular carcinoma

BACKGROUNDMany transcriptome-based signatures for hepatocellular carcinoma (HCC) prognosis have been reported, but most show limited portability across cohorts.We hypothesized that a network-guided analysis of harmonized liver transcriptomes could identify a biologically coherent and portable prognostic signature. AIMTo identify biologically coherent co-expression modules and develop a robust expression signature for HCC prognosis. METHODSWe used uniformly processed RNA-seq data from the University of California Santa Cruz Toil recompute compendium to integrate The Cancer Genome Atlas (TCGA)-liver HCC tumors (n = 371), TCGA adjacent non-tumor liver (n = 50), and Genotype-Tissue Expression normal liver (n = 110).After filtering out low-expression genes and selecting 8000 most variable ones according to their median absolute deviation, we performed weighted gene co-expression network analysis to identify co-expression modules in tumor and normal tissues, which was followed by hub-gene prioritization, enrichment analysis, least absolute shrinkage and selection operator-Cox modeling, external validation, and meta-analysis. RESULTSWeighted gene co-expression network analysis identified a tumor-associated module enriched for cell-cycle progression, mitotic checkpoint control, DNA replication, E2F targets, and mTORC1 signaling.A normal-liver-associated module showed a distinct expression module enriched for detoxification, metal-ion/toxin response, and liver 5 / 51 homeostatic functions.Cross-platform filtering, survival-analysis screening and least absolute shrinkage and selection operator-Cox modeling yielded a 3-gene signature consisting of MMP1, KIF2C, and HOXD10.In TCGA, the signature-based risk score was significantly associated with overall survival, and the association remained significant after adjustment for age at diagnosis, sex, and disease stage (hazard ratio = 2.95, 95% confidence interval: 1.92-4.53,P = 8.10 × 10 -7 ).The TCGA-derived coefficients were then applied to six external cohorts, with adverse prognostic associations observed in the same direction across all cohorts, although statistical significance varied among individual datasets.Random-effects meta-analysis yielded a pooled hazard ratio of 1.54 (95% confidence interval: 1.30-1.82)per 1-SD increase in risk score (I 2 = 39.8%). CONCLUSIONThe network-guided analysis of a harmonized TCGA-Genotype-Tissue Expression liver transcriptome identified a biologically coherent survival-related expression signature with cross-platform prognostic associations in retrospective cohorts.This signature represents a candidate prognostic model requiring prospective assay-based validation and evaluation of clinical utility.

Authors

Institutions

Publication Details

Journal
World Journal of Hepatology
Published
2026-11-13
DOI
https://doi.org/10.4254/wjh.125493
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Weighted gene co-expression network of tumor and normal liver transcriptomes identifies prognostic signature in hepatocellular carcinoma

Scott K. Kuwada, Shaoqiu Chen, Junlong Wang, Jaideep Behari et al.
1 links
World Journal of Hepatology
Hepatocellular Carcinoma Treatment and Prognosis
article

Weighted gene co-expression network of tumor and normal liver transcriptomes identifies prognostic signature in hepatocellular carcinoma

Scott K. Kuwada, Shaoqiu Chen, Junlong Wang, Jaideep Behari, Linda L. Wong, Chuong Tran, You-Ping Deng, Jian-Min Yuan, Li Ma, Herbert Yu
article en

Abstract

BACKGROUNDMany transcriptome-based signatures for hepatocellular carcinoma (HCC) prognosis have been reported, but most show limited portability across cohorts.We hypothesized that a network-guided analysis of harmonized liver transcriptomes could identify a biologically coherent and portable prognostic signature. AIMTo identify biologically coherent co-expression modules and develop a robust expression signature for HCC prognosis. METHODSWe used uniformly processed RNA-seq data from the University of California Santa Cruz Toil recompute compendium to integrate The Cancer Genome Atlas (TCGA)-liver HCC tumors (n = 371), TCGA adjacent non-tumor liver (n = 50), and Genotype-Tissue Expression normal liver (n = 110).After filtering out low-expression genes and selecting 8000 most variable ones according to their median absolute deviation, we performed weighted gene co-expression network analysis to identify co-expression modules in tumor and normal tissues, which was followed by hub-gene prioritization, enrichment analysis, least absolute shrinkage and selection operator-Cox modeling, external validation, and meta-analysis. RESULTSWeighted gene co-expression network analysis identified a tumor-associated module enriched for cell-cycle progression, mitotic checkpoint control, DNA replication, E2F targets, and mTORC1 signaling.A normal-liver-associated module showed a distinct expression module enriched for detoxification, metal-ion/toxin response, and liver 5 / 51 homeostatic functions.Cross-platform filtering, survival-analysis screening and least absolute shrinkage and selection operator-Cox modeling yielded a 3-gene signature consisting of MMP1, KIF2C, and HOXD10.In TCGA, the signature-based risk score was significantly associated with overall survival, and the association remained significant after adjustment for age at diagnosis, sex, and disease stage (hazard ratio = 2.95, 95% confidence interval: 1.92-4.53,P = 8.10 × 10 -7 ).The TCGA-derived coefficients were then applied to six external cohorts, with adverse prognostic associations observed in the same direction across all cohorts, although statistical significance varied among individual datasets.Random-effects meta-analysis yielded a pooled hazard ratio of 1.54 (95% confidence interval: 1.30-1.82)per 1-SD increase in risk score (I 2 = 39.8%). CONCLUSIONThe network-guided analysis of a harmonized TCGA-Genotype-Tissue Expression liver transcriptome identified a biologically coherent survival-related expression signature with cross-platform prognostic associations in retrospective cohorts.This signature represents a candidate prognostic model requiring prospective assay-based validation and evaluation of clinical utility.

World Journal of Hepatology
University of Hawaiʻi at Mānoa (US), Queen's Medical Center (US)
National Institutes of Health
Good health and well-being
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon